Search
meglitinide (Meglitinido, Meglitinidum)
Indications:
- treatment of diabetes mellitus type 2
Adverse effects:
- weight gain
- hypoglycemia [3]
Mechanism of action:
- hypoglycemic agent
- stimulates insulin secretion by pancreatic beta cells
Clinical trials:
- no long term outcome studies [3]
Interactions
drug interactions
drug adverse effects of hypoglycemic agents
Specific
nateglinide (Starlix)
repaglinide (Prandin)
General
benzamide
oral hypoglycemic agent
Database Correlations
PUBCHEM cid=41214
References
- PubChem: 41214
- Ganda OP.
Review: meglitinide analogues reduce glucose levels in
type 2 diabetes, but morbidity and mortality effects are
unknown.
ACP J Club. 2007 Nov-Dec;147(3):65
PMID: 17975867
- Medical Knowledge Self Assessment Program (MKSAP) 17,
American College of Physicians, Philadelphia 2015